06.04.2011 | PM

Signature Diagnostics to Present a novel Companion Diagnostic Product

Signature Diagnostics AG announced today that the company was selected to present its novel companion diagnostics for predicting response to Cetuximab in patients with colorectal cancer (CRC) of all stages at the 102nd Annual Meeting of the American Association for Cancer Research (AACR) in Orlando on April 2-6, 2011.

(Quelle: Reuters, 06.04.2011 Press Release Signature Diagnostics)

Lesen sie hier den ausführlichen Artikel:

www.reuters.com
Logo Signature